Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Until 5 days after the onset of swelling |
Susceptible HCWs should not provide care if immune caregivers are available. HCWs should use masks regardless of immune status. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Non-tuberculous mycobacteria (atypical), pulmonary or wound | |||
Tuberculosis, active pulmonary or laryngeal |
See Tuberculosis *Patients undergoing invasive procedures that may aerosolize require Airborne Isolation. Contact Infection Prevention. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Duration of illness |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Until 24 hrs after initiation of effective therapy |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Adult and pediatric hematology/oncology/BMT patients: Duration of hospitalization,. All others: Enteric Contact + Standard isolation can be discontinued if (1) patient has had no diarrhea for ≥48 hours AND (2) patient has been transferred to clean room. |
Hand Hygiene with soap and water (not alcohol based hand rub) is indicated upon exiting the room of a patient on Contact + Standard Isolation for norovirus. Wash your hands sign is available. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Adult and Pediatric hematology/oncology/BMT patients:
All other patients: Duration of illness |
Initiate isolation when test is ordered to rule out viral pathogens. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Duration of illness |
Additional resources are available on the parechovirus web page. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Immunosuppressed patient |
For duration of hospitalization when chronic disease occurs |
Duration of precautions for immunosuppressed patients with persistently positive PCR not defined, but transmission has occurred. |
|
Patient with transient aplastic or red-cell crisis |
Seven days from symptom onset if known. Use date of identification if symptom onset date unclear. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Until 5 days of effective antibiotic therapy |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
bubonic | |||
pneumonic |
Until 48 hrs after initiation of effective therapy |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Varicella-Zoster (See Varicella-Zoster) |
|
||
Viral, All patients |
See Respiratory Infectious Disease, acute, or specific viral agent |
||
Pneumonia, adenovirus |
|
Refer to Adenovirus-Respiratory Infection |
|
Bacterial, not listed elsewhere | |||
Burkholderia cepacia in cystic fibrosis patients, including respiratory tract colonization | |||
Burkholderia cepacia in patients without cystic fibrosis | |||
Chlamydia |